Time to include fine specificity anti‐citrullinated protein antibodies in the routine diagnosis and management of rheumatoid arthritis? by Schwenzer, A, Quirke, A, Montgomery, A, Sayles, H, Schlumberger, W, Payne, J, Mikuls, T, Venables, P, Midwood, K

Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis. by Schwenzer, A, Jiang, X, Mikuls, T, Payne, J, Sayles, H, Quirke, A, Kessler, B, Fischer, R, Venables, P, Lundberg, K, Midwood, K

Association of distinct fine specificities of anti-citrullinated peptide antibodies with elevated immune responses to Prevotella intermedia in a subgroup of patients with rheumatoi... by Schwenzer, A, Quirke, A, Marzeda, A, Wong, A, Montgomery, A, Sayles, H, Eick, S, Gawron, K, Chomyszyn-Gajewska, M, Łazarz-Bartyzel, K, Davis, S, Potempa, J, Kessler, B, Fischer, R, Venables, P, Payne, J, Mikuls, T, Midwood, K